Masthead
21 January 2020
21 January 2020
21 January 2020
21 January 2020
21 January 2020
21 January 2020
21 January 2020
21 January 2020
Vincenzo La Mura, Marta Garcia‐Guix, Annalisa Berzigotti, Juan G. Abraldes, Juan Carlos García‐Pagán, Candid Villanueva, Jaime Bosch – 20 January 2020
Albert Do, Nancy S. Reau – 20 January 2020 – The past decade has seen transformation in the strategies for identifying and managing viral hepatitis, most dramatically the transformation of hepatitis C virus from a mostly chronic affliction to a curable disease that is accessible to wide populations through direct‐acting antiviral therapies. More recently, shifting of hepatitis C virus burden to younger patients driven by intravenous drug use has shaped screening recommendations.